English
  • Ruxolitinib

    ʻO Ruxolitinib

    Ka inoa o ka API Hōʻike Mea hana hou Lā Hoʻopau Patent (ʻAmelika)
    ʻO Ruxolitinib Myelofibrosis Novartis Iulai 6, 2024
    ninaukikoʻī
  • Relugolix

    Relugolix

    Ka inoa o ka API Hōʻike Mea hana hou Lā Hoʻopau Patent (ʻAmelika)
    Relugolix Ka maʻi maʻi prostate Takeda a me ASKA Ian. 24, 2024
    ninaukikoʻī
  • Rimegepant

    Rimegepant

    Ka inoa o ka API Hōʻike Mea hana hou Lā Hoʻopau Patent (ʻAmelika)
    Rimegepant ʻO ka migraine headache Biohaven Feb. 22, 2031

     

    ninaukikoʻī
  • Relugolix 737789-87-6

    Relugolix 737789-87-6

    Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP
    Ribociclib CAS: 737789-87-6 Atineoplastic I-Hale      
    ninaukikoʻī
  • Ribociclib 1374639-75-4

    Ribociclib 1374639-75-4

    Ka inoa o ka API Hōʻike Mea hana hou Lā Hoʻopau Patent (ʻAmelika)
    Ribociclib 1374639-75-4 HR-maikaʻi, HER2-negative Andvance ormetastatic breast Cancers Novartis
    ʻO nā lāʻau lapaʻau    		 Iun.27, 2028
    ninaukikoʻī
  • Rivaroxaban

    Rivaroxaban

    Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP
    Rivaroxaban ʻAiʻaʻa I-Hale TDP    
    ninaukikoʻī
  • Rosuvastatin Calcium

    ʻO Rosuvastatin Calcium

    Ka inoa o ka API Hōʻike Hōʻike US DMF EU DMF CEP
    ʻO Rosuvastatin Calcium Hypercholesterolemia I-Hale/CEP 20705 √ CEP2015-240
    ninaukikoʻī